#009 $MRVI: MRVI Meltdown: When Biotech's Books Go Bad

When Maravai LifeSciences (MRVI) misreported $3.9 million in revenue, it wasn’t just a bad math day—it triggered a stock crash and a class-action lawsuit. In this episode of Bulls & Betrayal: Holding Wall Street Accountable, Anna and Nate break down how mistimed revenue, goodwill impairments, and “effective internal controls” turned into investor nightmares. If you're a retail investor, finance nerd, or just love some forensic accounting drama, this deep dive is for you.

We’re not lawyers or accountants, so don’t take this as legal or financial advice.

🎧 Catch the full breakdown + more at ZLK.com and follow us on socials for updates.